Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Allogene Therapeutics Inc (NASDAQ:ALLO) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 25.93M à 24.45M. Cela représente 13.54% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Allogene Therapeutics Corp (XNAS:ALLO) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 3.90M actions échangées par jour, il faudrait 6.27 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
24.45M
Intérêt à court terme %
13.5%
Jours de couverture
6.27
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 13.54% | 180,654,817 | 24,454,034 | 3,901,958 | 6.27 | |
ALLO | Allogene Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 14.35% | 180,654,817 | 25,930,643 | 3,818,488 | 6.79 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 14.71% | 180,654,817 | 26,572,188 | 2,558,644 | 10.39 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 14.42% | 180,654,817 | 26,041,918 | 2,703,576 | 9.63 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 13.60% | 180,654,817 | 24,567,671 | 2,362,601 | 10.4 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 15.15% | 180,654,817 | 27,361,306 | 5,324,896 | 5.14 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 19.22% | 156,710,201 | 30,125,461 | 2,247,050 | 13.41 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 20.94% | 156,710,201 | 32,811,049 | 3,167,452 | 10.36 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 22.18% | 156,710,201 | 34,756,318 | 3,514,828 | 9.89 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 24.26% | 156,710,201 | 38,012,142 | 3,259,936 | 11.66 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 26.22% | 149,117,554 | 39,095,990 | 14,864,570 | 2.63 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 22.57% | 149,117,554 | 33,662,897 | 6,638,865 | 5.07 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 21.49% | 149,117,554 | 32,048,327 | 2,305,377 | 13.9 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 21.70% | 149,117,554 | 32,352,285 | 3,269,259 | 9.9 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 20.73% | 149,117,554 | 30,906,822 | 2,890,694 | 10.69 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 21.71% | 149,117,554 | 32,371,979 | 2,335,231 | 13.86 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 20.90% | 149,117,554 | 31,167,763 | 2,703,155 | 11.53 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 23.50% | 149,117,554 | 35,047,242 | 2,722,218 | 12.87 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 24.84% | 149,117,554 | 37,040,821 | 1,953,521 | 18.96 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 26.47% | 148,556,979 | 39,318,504 | 1,705,003 | 23.06 | |
ALLO | Allogene Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 25.92% | 148,556,979 | 38,512,665 | 2,170,473 | 17.74 | |
ALLO | Allogene Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 26.38% | 148,556,979 | 39,187,976 | 1,742,881 | 22.48 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 26.21% | 148,556,979 | 38,940,757 | 1,695,830 | 22.96 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/15/2024 | 08/26/2024 | 26.41% | 148,556,979 | 39,229,292 | 1,762,681 | 22.26 | |
ALLO | Allogene Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 25.41% | 148,556,979 | 37,750,648 | 2,757,295 | 13.69 | |
ALLO | Allogene Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 29.16% | 148,229,877 | 43,225,799 | 2,382,360 | 18.14 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 27.92% | 148,229,877 | 41,384,695 | 4,275,506 | 9.68 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 29.20% | 148,229,877 | 43,277,309 | 2,594,733 | 16.68 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 27.37% | 148,229,877 | 40,567,051 | 3,207,724 | 12.65 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 24.58% | 148,229,877 | 36,428,594 | 2,167,686 | 16.81 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 30.71% | 110,298,842 | 33,867,289 | 2,055,356 | 16.48 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 28.47% | 110,168,563 | 31,360,608 | 1,632,502 | 19.21 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 26.60% | 115,114,793 | 30,621,417 | 1,841,688 | 16.63 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 24.11% | 115,114,793 | 27,749,018 | 3,336,219 | 8.32 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 21.81% | 114,665,039 | 25,007,919 | 2,050,440 | 12.2 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/15/2024 | 02/27/2024 | 20.51% | 114,299,463 | 23,447,504 | 2,568,749 | 9.13 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 20.20% | 114,299,463 | 23,085,975 | 2,491,223 | 9.27 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 26.43% | 114,299,463 | 30,205,958 | 4,202,446 | 7.19 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 27.40% | 114,299,463 | 31,323,687 | 2,799,115 | 11.19 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 29.36% | 114,299,463 | 33,553,816 | 4,021,844 | 8.34 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 27.87% | 114,299,463 | 31,856,812 | 2,260,169 | 14.09 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 28.30% | 114,299,463 | 32,343,375 | 2,593,793 | 12.47 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 29.77% | 114,299,463 | 34,031,762 | 1,219,784 | 27.9 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/13/2023 | 10/24/2023 | 27.04% | 113,649,166 | 30,729,965 | 1,308,808 | 23.48 | |
ALLO | Allogene Therapeutics, Inc. Co | 09/29/2023 | 10/10/2023 | 30.03% | 113,649,166 | 34,128,981 | 1,449,297 | 23.55 | |
ALLO | Allogene Therapeutics, Inc. Co | 09/15/2023 | 09/26/2023 | 29.40% | 113,649,166 | 33,416,055 | 2,094,873 | 15.95 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/31/2023 | 09/12/2023 | 28.25% | 113,649,166 | 32,105,389 | 1,333,399 | 24.08 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/15/2023 | 08/24/2023 | 28.83% | 113,649,166 | 32,768,529 | 2,709,771 | 12.09 |
À la recherche des actions les plus vendues à découvert?